Eosinophilic-Associated Diseases Charity EOS Network

Fasenra Approved in China For Severe Eosinophilic Asthma Patients

Fasenra (Benralizumab) gains approval in China for treating severe eosinophilic asthma, offering new hope to millions of patients with limited treatment options. Learn more about this significant advancement Read more
Pollen Season and EoE: How It Affects Diet Treatment

Pollen season can lower the response rate to the six-food elimination diet (SFED) in patients with Eosinophilic Oesophagitis (EoE), study shows. Read more
High Prevalence of GI Disorders in Joint Hypermobility Patients. Study Findings

The study shows a high prevalence of GI disorders in hEDS/JHS patients, including constipation, dysphagia, and Eosinophilic Diseases. Read more
Guidelines for Childhood Eosinophilic Gastrointestinal Disorders Beyond EoE by ESPGHAN/NASPGHAN

Explore the latest guidelines on Non-Eosinophilic Oesophagitis (Non-EoE) EGIDs in childhood, including challenges in development and implications for clinical and research practice. Read more

Help us confront Eosinophilic Diseases together!
Find out about EOS Network and ways you can get involved below.

Amanda's Message: Our Achievements And New Challenges

Eosinophilic Awareness Month ended with our gratitude for support. Through Eosinophilic Voices and collaborations, we raised awareness and facilitated early recognition of symptoms. Your support is vital in achieving our mission for prompt diagnosis, treatment, and holistic care for EAD patients.

What we do

EOS Network is a global platform dedicated to confronting eosinophilic diseases. We ensure prompt diagnosis right treatment, and provide support for patients. Join us today to make a difference.

Thank you for supporting our mission

Eosinophilic Gastrointestinal Diseases (EGIDs) website banner

Make a donation

Latest news

Gut Microbes Linked to Long-Term Allergies by Affecting Immune Cells and IgE Production

New research shows how early-life changes in gut bacteria can increase the risk of lifelong allergic diseases, offering insights into potential future treatments. Read more
Fasenra Approved in China For Severe Eosinophilic Asthma Patients

Fasenra (Benralizumab) gains approval in China for treating severe eosinophilic asthma, offering new hope to millions of patients with limited treatment options. Learn more about this significant advancement Read more
Discovering Mast Cells' Role in Eosinophilic Oesophagitis with Machine Learning

Explore how a recent study used machine learning to localise and characterise mast cells in the pathology of EoE. Read more
EOS Network Advocacy: Key Highlights from ESPGHAN 2024 Annual Meeting

Learn more about our paediatric care advocacy, networking and learn about the latest research we bring from the ESPGHAN Annual Meeting Read more

Supporting EOS Network

Regular gift

The demand for our services is growing. Help us reach out and support those that need us, pledge your gift of support today. Read more
EOS Network: Thank You To All Our Supporters

Thank you for supporting our mission and helping us to ensure that every person with an Eosinophilic-Associated Disease receives a prompt, accurate diagnosis, the right treatment for them, and support to live with their condition. Read more